Avid Bioservices Inc (CDMO)
12.21
+0.01
(+0.08%)
USD |
NASDAQ |
Nov 14, 12:29
Avid Bioservices Cash from Operations (Quarterly): -3.68M for July 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | -3.68M |
| April 30, 2024 | 1.257M |
| January 31, 2024 | 3.687M |
| October 31, 2023 | 6.244M |
| July 31, 2023 | -0.236M |
| April 30, 2023 | 3.145M |
| January 31, 2023 | -6.941M |
| October 31, 2022 | -3.837M |
| July 31, 2022 | -5.089M |
| April 30, 2022 | 0.612M |
| January 31, 2022 | 5.192M |
| October 31, 2021 | 10.60M |
| July 31, 2021 | -6.942M |
| April 30, 2021 | 17.86M |
| January 31, 2021 | 5.189M |
| October 31, 2020 | 10.41M |
| July 31, 2020 | -2.273M |
| April 30, 2020 | 3.047M |
| January 31, 2020 | -0.636M |
| October 31, 2019 | 5.884M |
| July 31, 2019 | -2.468M |
| April 30, 2019 | 5.648M |
| January 31, 2019 | -3.082M |
| October 31, 2018 | -6.713M |
| July 31, 2018 | -7.448M |
| Date | Value |
|---|---|
| April 30, 2018 | 2.109M |
| January 31, 2018 | -8.633M |
| October 31, 2017 | -7.258M |
| July 31, 2017 | -12.21M |
| April 30, 2017 | -11.55M |
| January 31, 2017 | -10.83M |
| October 31, 2016 | 1.135M |
| July 31, 2016 | -17.92M |
| April 30, 2016 | -5.617M |
| January 31, 2016 | -7.398M |
| October 31, 2015 | -9.344M |
| July 31, 2015 | -17.23M |
| April 30, 2015 | -2.408M |
| January 31, 2015 | -9.456M |
| October 31, 2014 | -11.51M |
| July 31, 2014 | -12.64M |
| April 30, 2014 | -6.509M |
| January 31, 2014 | -8.135M |
| October 31, 2013 | -5.486M |
| July 31, 2013 | -8.124M |
| April 30, 2013 | -4.716M |
| January 31, 2013 | -6.552M |
| October 31, 2012 | -9.557M |
| July 31, 2012 | -0.101M |
| April 30, 2012 | -8.736M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-6.942M
Minimum
Jul 2021
17.86M
Maximum
Apr 2021
1.979M
Average
1.257M
Median
Apr 2024
Cash from Operations (Quarterly) Benchmarks
| MEI Pharma Inc | -18.00M |
| Altimmune Inc | -18.11M |
| NovaBay Pharmaceuticals Inc | -0.578M |
| Palatin Technologies Inc | -6.472M |
| iBio Inc | -4.854M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.311M |
| Cash from Financing (Quarterly) | 0.266M |
| Free Cash Flow | -11.45M |
| Free Cash Flow Per Share (Quarterly) | -0.0784 |
| Free Cash Flow to Equity (Quarterly) | -5.265M |
| Free Cash Flow to Firm (Quarterly) | -2.537M |
| Free Cash Flow Yield | -1.48% |